CPT1A Supports Castration-Resistant Prostate Cancer in Androgen-Deprived Conditions

CPT1A Supports Castration-Resistant Prostate Cancer in Androgen-Deprived Conditions

Prostate cancer (PCa) is the most common cancer in men, and the global burden of the disease is rising. The majority of PCa deaths are due to metastasis that are highly resistant to current hormonal treatments; this state is called castration-resistant prostate cancer (CRPC). In this study, we focus...

Full description

Bibliographic Details
Main Authors: Molishree Joshi, Gergana E. Stoykova, Maren Salzmann-Sullivan, Monika Dzieciatkowska, Lauren N. Liebman, Gagan Deep, Isabel R. Schlaepfer
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Cells
Subjects:
<i>CPT1A</i>
prostate cancer
androgen receptor
histone acetylation
enzalutamide
dihydrotestosterone
Online Access:https://www.mdpi.com/2073-4409/8/10/1115

Internet

https://www.mdpi.com/2073-4409/8/10/1115

Similar Items